389 related articles for article (PubMed ID: 16458533)
1. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
Masteller EL; Tang Q; Bluestone JA
Semin Immunol; 2006 Apr; 18(2):103-10. PubMed ID: 16458533
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
3. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
4. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
Porter CM; Horvath-Arcidiacono JA; Singh AK; Horvath KA; Bloom ET; Mohiuddin MM
Xenotransplantation; 2007 Jul; 14(4):298-308. PubMed ID: 17669171
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.
Fisson S; Djelti F; Trenado A; Billiard F; Liblau R; Klatzmann D; Cohen JL; Salomon BL
Eur J Immunol; 2006 Apr; 36(4):817-27. PubMed ID: 16525991
[TBL] [Abstract][Full Text] [Related]
6. Donor reactive regulatory T cells.
Feng G; Chan T; Wood KJ; Bushell A
Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific regulatory T-cell subsets in transplantation tolerance regulatory T-cell subset quality reduces the need for quantity.
Koenen HJ; Joosten I
Hum Immunol; 2006 Sep; 67(9):665-75. PubMed ID: 17002896
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
9. The blind-spot of regulatory T cells.
Graça L; Silva-Santos B; Coutinho A
Eur J Immunol; 2006 Apr; 36(4):802-5. PubMed ID: 16572390
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of expanded CD4+25+ cells.
June CH; Blazar BR
Semin Immunol; 2006 Apr; 18(2):78-88. PubMed ID: 16458015
[TBL] [Abstract][Full Text] [Related]
13. Superiority of bone marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque.
Moreau A; Chiffoleau E; Beriou G; Deschamps JY; Heslan M; Ashton-Chess J; Rolling F; Josien R; Moullier P; Cuturi MC; Alliot-Licht B
Transplantation; 2008 May; 85(9):1351-6. PubMed ID: 18475195
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients.
Wang Z; Fu XY; Shi BY; Qian YY; Xiao L; Bai HW
Transplant Proc; 2009 Jun; 41(5):1574-6. PubMed ID: 19545682
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
Miyara M; Wing K; Sakaguchi S
J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
[TBL] [Abstract][Full Text] [Related]
16. Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide.
Larkin J; Picca CC; Caton AJ
Eur J Immunol; 2007 Jan; 37(1):139-46. PubMed ID: 17154263
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
18. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.
Chen LC; Delgado JC; Jensen PE; Chen X
J Immunol; 2009 Sep; 183(6):4094-102. PubMed ID: 19684083
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
20. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]